Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/40673
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nasreddine, Rakan | - |
dc.contributor.author | Florence, Eric | - |
dc.contributor.author | Yombi, Jean Cyr | - |
dc.contributor.author | Henrard, Sophie | - |
dc.contributor.author | Darcis, Gilles | - |
dc.contributor.author | Van Praet, Jens | - |
dc.contributor.author | Vandekerckhove, Linos | - |
dc.contributor.author | Allard, Sabine | - |
dc.contributor.author | Demeester, Rémy | - |
dc.contributor.author | MESSIAEN, Peter | - |
dc.contributor.author | Ausselet, Nathalie | - |
dc.contributor.author | Delforge, Marc | - |
dc.contributor.author | De Wit, Stéphane | - |
dc.date.accessioned | 2023-08-03T13:25:56Z | - |
dc.date.available | 2023-08-03T13:25:56Z | - |
dc.date.issued | 2022 | - |
dc.date.submitted | 2023-08-03T13:24:16Z | - |
dc.identifier.citation | HIV Glasgow, Glasgow, 23 – 26 October 2022 | - |
dc.identifier.uri | http://hdl.handle.net/1942/40673 | - |
dc.description.abstract | Conclusion • Several RCTs have demonstrated BIC/FTC/TAF to be a first-line option for treatment-naïve and experienced PLWH [1-4]. • Real-world studies provide complementary information to RCTs and ensure that those results can be generalized to broader populations seen in daily practice. • The aim of this study was to describe the Belgian HIV population treated with BIC/FTC/TAF and to evaluate its efficacy, durability, and tolerability in a real-world setting. | - |
dc.language.iso | en | - |
dc.title | A retrospective, multicenter study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in Belgium | - |
dc.type | Conference Material | - |
local.bibliographicCitation.conferencedate | 23 – 26 October 2022 | - |
local.bibliographicCitation.conferencename | HIV Glasgow | - |
local.bibliographicCitation.conferenceplace | Glasgow | - |
local.bibliographicCitation.jcat | C2 | - |
local.contributor.corpauthor | Belgian Research on AIDS and HIV Consortium (BREACH) | - |
local.type.refereed | Non-Refereed | - |
local.type.specified | Conference Poster | - |
local.provider.type | - | |
local.uhasselt.international | no | - |
item.fullcitation | Nasreddine, Rakan; Florence, Eric; Yombi, Jean Cyr; Henrard, Sophie; Darcis, Gilles; Van Praet, Jens; Vandekerckhove, Linos; Allard, Sabine; Demeester, Rémy; MESSIAEN, Peter; Ausselet, Nathalie; Delforge, Marc & De Wit, Stéphane (2022) A retrospective, multicenter study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in Belgium. In: HIV Glasgow, Glasgow, 23 – 26 October 2022. | - |
item.contributor | Nasreddine, Rakan | - |
item.contributor | Florence, Eric | - |
item.contributor | Yombi, Jean Cyr | - |
item.contributor | Henrard, Sophie | - |
item.contributor | Darcis, Gilles | - |
item.contributor | Van Praet, Jens | - |
item.contributor | Vandekerckhove, Linos | - |
item.contributor | Allard, Sabine | - |
item.contributor | Demeester, Rémy | - |
item.contributor | MESSIAEN, Peter | - |
item.contributor | Ausselet, Nathalie | - |
item.contributor | Delforge, Marc | - |
item.contributor | De Wit, Stéphane | - |
item.fulltext | With Fulltext | - |
item.accessRights | Open Access | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
poster 9 PowerPoint Presentation.pdf | Conference material | 943.06 kB | Adobe PDF | View/Open |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.